Noventra Pharma Retrexa (44mg Pre-Filled Pen – Retatrutide & Naltrexone Blend)

Retrexa 44mg Pre-Filled Pen by Noventra Pharma is an advanced peptide-based formulation designed to support metabolic regulation, appetite control, and overall body composition. This hybrid formulation combines retatrutide, a triple agonist targeting GLP-1, GIP, and glucagon receptors, with naltrexone, a centrally acting compound associated with appetite and reward pathway modulation. It integrates peripheral metabolic signalling with central appetite regulation. Key Features: - 44mg combined formulation: retatrutide + naltrexone - Triple agonist activity involving GLP-1, GIP, and glucagon pathways - Central appetite modulation via naltrexone - Supports appetite regulation and reduced caloric intake - Promotes metabolic efficiency and fat loss pathways - Multi-pathway approach: metabolic + neurological support - Pre-filled pen for precise and consistent dosing Suggested Use: Typically administered in controlled doses as part of a structured protocol. Dosing is often introduced gradually and adjusted based on individual response and tolerance. Always follow guidance from a qualified healthcare provider. Storage: Refrigerate at 2–8°C. Do not freeze. Protect from light. Important Information: This product is intended for use under medical supervision only. Due to its advanced multi-pathway mechanism, it is recommended for structured or experienced protocols. Not suitable for individuals with certain medical conditions. Not recommended for persons under 18, pregnant or breastfeeding individuals. Always consult a qualified healthcare provider before use.